Full-Time Faculty

Name Chia-Hung Hsieh Chia-Hung Hsieh
  • Associate Professor
  • E-mail: chhsiehcmu @ mail.cmu.edu.tw
  • Office: Cancer Center 7F, Cancer Center Building, China Medical University , 91 Hsueh-Shih Road, Taichung 40402, Taiwan, ROC.
  • Tel: +886-4-22052121 ext 7712
  • Fax:  886-4-22333641
Resume Degrees
  • National Yang Ming University and Academia Sinica Taipei, Taiwan
  • 2003-2006 Ph.D., Molecular Medicine Program ,Ph.D., Development of Biomedical Imaging and Radiological Sciences
  • National Yang Ming University Taipei, Taiwan
  • 2001-2003 Master of Science, Institute of Radiological Sciences
  • Academia Sinica
  • 2006.2-2006.7 Post doctoral fellow, NRPGM Molecular-Genetic Imaging Core
  • Armed Forces Taichung General Hospital Taichung, Taiwan
  • 1999-2001 Second lieutenant of medical officer, Department of Radiology
Academic Honors and Awards
  • Excellent Ph.D. thesis Award of National Yang-Ming University (2006)
  • The Young Investigator and Student Travel Stipend Award of Fifth Annual Meeting of the Society for Molecular Imaging (2006)
  • Honor Membership of The Phi Tau Phi Scholastic Honor Society (2007)
  • Young Investigator Awards of the Society for World Molecular Imaging (2009)
Research Field of Interest
  • Molecular Imaging
  • Molecular Therapy
  • Stem Cell Therapy
  • Molecular Mechanism of Cancer and Inflammation diseases
  • Radiation Oncology
Lab Introduction

Molecular imaging is a rapidly emerging field, providing noninvasive visual quantitative representations of fundamental biological processes in intact living subjects. Fundamental biomedical research stands to benefit considerably from advances in molecular imaging, with improved molecular target selection, probe development and imaging instrumentation. The noninvasiveness of molecular imaging technologies will also provide benefit through improved patient care. Molecular imaging endpoints can be
quantified, and therefore are particularly useful for translational research. Integration of the two disciplines of molecular imaging and molecular medicine, combined with systems-biology approaches to understanding disease complexity, promises to provide predictive, preventative and personalized medicine that will transform healthcare. In the past, our researches are focused on developing several novel approaches, such as novel molecular probes and reporter genes, in the molecular-genetic imaging,molecular-targeting imaging, in vivo cell trafficking imaging and in vivo molecularinteraction imaging. These approaches will be to provide the potential for:
(i) understanding a living subject abnormal biology in a more rapid and noninvasive manner, and with less labour than is the case with conventional pathology- or clinical chemistry-based assays;
(ii) earlier detection and characterization of disease and its pathogenesis and
(iii) rapid assessment of therapeutic effectiveness at a molecular level, long before phenotypic change.
At present, we are utilizing these developed approaches to investigate the molecular pathology and to create the imaging tool for early diagnosis in cancer, cardiovasculardisease, neurosciences and inflammation diseases.

Fields of Specialty
  • Molecular imaging
  • Molecular medicine
  • Molecular cell biology
  • Tumor biology
  • Radiological Sciences
  • Radiobiology
  • Nuclear medicine